“Ruxolitinib Cream is Associated With Reduced Treatment Burden in Atopic Dermatitis: A US Payer Claim Analysis” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s591. doi:10.25251/9yfem502.